South Wales, Sept. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Emarexene" on Sept. 8. The details about the trademark application no. UK00004261133 published in the journal no. 2025/038 (Sept. 19).
With Trama Legal s.r.o. as representative, MRX Medical Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Medicinal oils, other than essential oils; Anti-inflammatory preparations; Pharmaceutical preparations and substances with anti-inflammatory properties; Analgesics; Anti-infectives; Pharmaceutical preparations; Pharmaceutical preparations for the treatment of heart rhythm disorders; Plant extracts, other than essential oils, for pharmaceutical purposes; Pharmaceutical preparations for treatment of endometriosis and endometriosis-associated pain; Pharmaceutical preparations for treatment of refractory epilepsies; Pharmaceutical preparations for treatment of chemotherapy-induced peripheral neuropathy; Pharmaceutical preparations for treatment of cardiac fibrosis including heart failure with preserved ejection fraction; Oil-based pharmaceutical preparations; Pharmaceutical preparations for treatment of hematologic related conditions.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004261133
Disclaimer: Curated by HT Syndication.
